Pain aggravation: the human cost of medicine price hikes

After Advanz’s £100m fine over the price of its thyroid tablets, two people recount the difficulty of obtaining medication

The UK’s competition watchdog has fined pharmaceutical company Advanz over £100m for inflating the price of its thyroid tablets by up to 6,000%. The exorbitant costs resulted in NHS clinical commissioning groups advising doctors not to prescribe liothyronine, locking out many people who depended on the tablets to alleviate the symptoms of hypothyroidism.

Without their tablets, some patients experienced the return of symptoms such as depression and fatigue or were forced to turn to online pharmacies, where they risked buying fake products.

Here two readers share how difficult obtaining the tablets was after the price hikes.

Lyn Mynott, 67, chief executive of Thyroid UK

Lyn Mynott
Lyn Mynott Photograph: HANDOUT

I asked my GP if I could go on liothyronine and it got rid of almost all of my symptoms so I could go back to work full-time. I had been on it for years and then the NHS “drop list” went out, and I got a letter from my surgery saying I was going to have it withdrawn, just like that. I went to my GP to have a chat and he said it was out of his hands.

So I was stuck and I thought “oh my God, what do I do now?”. I knew some people were accessing it via private prescription, but my GP wouldn’t give me one. This meant I would have to start paying for a private doctor’s consultation, which costs between £150 and £400.

In the beginning, I did notice a downturn in my symptoms because liothyronine is fast-acting; it’s out of the body in eight hours. I got back pain, muscle aches, tiredness and dizzy spells.

So I thought, I’ll have to get it for myself online, and in the beginning I got the UK brand which was very expensive – £246 for one month’s supply. Then I found it from a pharmacy in Europe without a prescription, which wasn’t what I wanted so it caused me a lot of stress, but it’s £35 plus postage.

I worry whether I’m getting the right thing because it’s not the UK brand, and when you buy online you do worry whether you’re getting a fake product. I don’t think it is because I’ve felt well on it, but it’s a concern. In my job I see a lot of people getting theirs from various places, like Greece and Turkey, and you think “goodness, I’m not sure that’s a good thing”. As a charity we don’t advocate buying it online.

It makes me very angry, very frustrated.

David Durell, speaking on behalf of Janet Durell, 86, who has Alzheimer’s

Janet Durell
Janet Durell Photograph: HANDOUT

Janet wasn’t doing well before she started taking liothyronine. She used to sweat profusely even when it was cold. She was like a blimming zombie. We saw the thyroid tablets on a TV programme and asked the doctor, and she said “I can’t prescribe it anyway on the NHS”, so we got Janet a private prescription, which was £10 per tablet in 2018, £300 a month. It was like a magic bullet – it changed her totally, she got more energy.

But because of the price I started to do some investigation. I was a bit uncertain about buying it on the internet so I went to the doctor and she gave me a private prescription, which I sent to Germany. They posted me 100 tablets at about 27 pence per tablet. I could have got it from Turkey for about the same price, but I was unsure if it was a proper pharmaceutical product I was buying.

Since then, my wife’s been referred to an endocrinologist and he agrees she needs liothyronine but he says the clinical commissioning group won’t allow him to supply them because they’ve been withdrawn from the NHS due to the cost.

Now that the CMA has sued this company, if GPs start prescribing again at a lower price we will go back to them.


Rachel Hall

The GuardianTramp

Related Content

Article image
UK pharma firms accused of illegal deals to hike price of life-saving drug
Actavis charged NHS 80% more for hydrocortisone tablets after incentivising rival Concordia not to launch its own version, watchdog claims

Angela Monaghan

03, Mar, 2017 @12:54 PM

Article image
Price gouging fine for Advanz is a rare story that is becoming common | Phillip Inman
Competition and Markets Authority is working on a string of cases involving the NHS being overcharged for drugs

Phillip Inman

29, Jul, 2021 @6:34 PM

Article image
Pfizer fined record £84.2m over NHS overcharging
Competition regulator says price of anti-epilepsy drug was increased by up to 2,600%

Angela Monaghan

07, Dec, 2016 @8:01 AM

Article image
Drug firm that hiked prices by 6,000% paid shareholders £400m
Advanz Pharma and former private equity owners were fined £100m by markets watchdog

Rob Davies

30, Jul, 2021 @2:17 PM

Article image
Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs
Competition regulator the CMA alleges drugs firms abused dominant position with unfairly high prices

Jillian Ambrose

05, Aug, 2021 @3:48 PM

Article image
Drug firm Concordia overcharged NHS with 6,000% price rise, says watchdog
CMA accuses Canadian firm of overcharging by £100m on thyroid drug with price per pack rising from £4.46 to £258 in 10 years

Julia Kollewe

21, Nov, 2017 @1:50 PM

Article image
Pharma firm Advanz fined after thyroid drug price hike of 6,000%
Competition watchdog found company’s ‘excessive and unfair’ prices cost NHS almost £30m extra over 10 years

Jillian Ambrose and Rob Davies

29, Jul, 2021 @7:21 AM

Article image
UK regulator tells Covid travel test firms to ‘get on right side of the law’
CMA threatens enforcement action after allegations of poor service for travellers arriving in England

Rob Davies

25, Aug, 2021 @1:30 PM

Article image
Motorola faces price controls over UK emergency services radio contract
Watchdog to rule on monopoly of police, fire and ambulance services system as excess profits head towards £1.1bn

Mark Sweney

14, Oct, 2022 @12:11 PM

Article image
Watchdog fines Pfizer and Flynn £70m for overcharging NHS for epilepsy drug
Penalties come after an in-depth investigation carried out by the Competition and Markets Authority

Julia Kollewe

21, Jul, 2022 @11:39 AM